...
首页> 外文期刊>The biochemical journal >Anti-(herpes simplex virus) activity of 4′-thio-2′-deoxyuridines: a biochemical investigation for viral and cellular target enzymes
【24h】

Anti-(herpes simplex virus) activity of 4′-thio-2′-deoxyuridines: a biochemical investigation for viral and cellular target enzymes

机译:4'-硫代-2'-脱氧尿苷的抗(单纯疱疹病毒)活性:病毒和细胞靶标酶的生化研究

获取原文
           

摘要

pThe antiviral activity of several nucleoside analogues is often limited by their rapid degradation by pyrimidine nucleoside phosphorylases. In an attempt to avoid this degradation, several modified nucleosides have been synthesized. A series of 4′-thio-2′-deoxyuridines exhibits an anti-[herpes simplex virus (HSV)] activity significantly higher (20–600 times) than that shown by the corresponding 4′-oxy counterpart. We investigated the mode of action of these compounds and we found that: (i) several 4′-thio-2′-deoxyuridines are phosphorylated to the mono- and di-phosphates by HSV-1 thymidine kinase (TK) more efficiently than their corresponding 4′-oxy counterpart; (ii) both are inhibitors of cellular thymidylate synthase; (iii) 4′-thio-2′-deoxyuridines are resistant to phosphorolysis by human thymidine phosphorylase; (iv) both 4′-oxy- and 4′-thio-2′-deoxyuridines are phosphorylated to deoxyribonucleotide triphosphate in HSV-1-infected cells and are incorporated into viral DNA; (v) 4′-thio-2′-deoxyuridines are better inhibitors than their 4′-oxy counterparts of [sup3/supH]thymidine incorporation in HSV-1-infected cells; (vi) 4′-thio-2′-deoxyuridines are not recognized by HSV-1 and human uracil-DNA glycosylases. Our data suggest that 4′-thio-2′-deoxyuridines, resistant to pyrimidine phosphorylase, can be preferentially or selectively phosphorylated by viral TK in HSV-infected cells, where they are further converted into triphosphate by cellular nucleotide kinases. Once incorporated into viral DNA, they are better inhibitors of viral DNA synthesis than their corresponding 4′-oxy counterpart, either because they are not recognized, and thus not removed, by viral uracil-DNA glycosylase, or because they preferentially interfere with viral DNA polymerase./p
机译:几种核苷类似物的抗病毒活性通常受到嘧啶核苷磷酸化酶快速降解的限制。为了避免这种降解,已经合成了几种修饰的核苷。一系列4'-硫-2'-脱氧尿苷显示出比相应的4'-氧对应物更高的抗[单纯疱疹病毒(HSV)]活性(20-600倍)。我们研究了这些化合物的作用方式,发现:(i)一些4'-硫代-2'-脱氧尿苷比HSV-1胸苷激酶(TK)更有效地被磷酸化为单磷酸和二磷酸。相应的4'-氧基对应物; (ii)两者都是细胞胸苷酸合酶的抑制剂; (iii)4'-硫代-2'-脱氧尿苷对人胸苷磷酸化酶的磷酸分解具有抗性; (iv)在被HSV-1感染的细胞中,将4'-氧-和4'-硫代2'-脱氧尿苷都磷酸化为脱氧核糖核苷酸三磷酸,并掺入病毒DNA中; (v)4'-硫代-2'-脱氧尿苷比在感染HSV-1的细胞中掺入[ 3 H]胸苷的4'-氧对应物更好。 (vi)HSV-1和人尿嘧啶-DNA糖基化酶无法识别4'-thio-2'-脱氧尿苷。我们的数据表明,对嘧啶磷酸化酶具有抗性的4'-硫代2'-脱氧尿苷可以在被HSV感染的细胞中被病毒TK优先或选择性地磷酸化,然后通过细胞核苷酸激酶进一步转化为三磷酸。一旦掺入病毒DNA中,它们便是比其相应的4'-氧对应物更好的病毒DNA合成抑制剂,因为它们未被病毒尿嘧啶-DNA糖基化酶识别并因此未被清除,或者因为它们优先干扰病毒DNA聚合酶。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号